1.
Role of FDG PET/CT in monitoring treatment response in patients with invasive fungal infections
by Ankrah, Alfred O
European journal of nuclear medicine and molecular imaging, 2019, Vol.46 (1), p.174-183
2.
How to scan who: the delicate balance between selecting the patient and selecting the imaging protocol
by Hustinx, Roland
European journal of nuclear medicine and molecular imaging, 2016, Vol.44 (1), p.5-7
3.
FDG PET/CT for assessing tumour response to immunotherapy: Report on the EANM symposium on immune modulation and recent review of the literature
by Aide, Nicolas
European journal of nuclear medicine and molecular imaging, 2018, Vol.46 (1), p.238-250
4.
Simple dichotomous assessment of cranial artery inflammation by conventional 18F-FDG PET/CT shows high accuracy for the diagnosis of giant cell arteritis: a case-control study
by Nielsen, Berit Dalsgaard
European journal of nuclear medicine and molecular imaging, 2018, Vol.46 (1), p.184-193
5.
The role of FDG-PET/CT imaging in early detection of extra-cardiac complications of infective endocarditis
by Orvin, K
Clinical microbiology and infection, 2015, Vol.21 (1), p.69-76
6.
FDG PET/CT used in identifying adult-onset Still’s disease in connective tissue diseases
by Zhou, Xin
Clinical rheumatology, 2020, Vol.39 (9), p.2735-2742
7.
Practice-based evidence for the clinical benefit of PET/CT—results of the first oncologic PET/CT registry in Germany
by Pfannenberg, Christina
European journal of nuclear medicine and molecular imaging, 2018, Vol.46 (1), p.54-64
8.
68 Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients
by Caroli, Paola
European journal of nuclear medicine and molecular imaging, 2018, Vol.45 (12), p.2035
9.
Pulmonary 18F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF)
by Win, Thida
European journal of nuclear medicine and molecular imaging, 2018, Vol.45 (5), p.806-815
10.
Added diagnostic value of respiratory-gated 4D 18F–FDG PET/CT in the detection of liver lesions: a multicenter study
by Crivellaro, Cinzia
European journal of nuclear medicine and molecular imaging, 2017, Vol.45 (1), p.102-109
11.
Contribution of PET imaging to mortality risk stratification in candidates to lead extraction for pacemaker or defibrillator infection: a prospective single center study
by Diemberger, Igor
European journal of nuclear medicine and molecular imaging, 2018, Vol.46 (1), p.194-205
12.
Fluorine-18 labeled fluorodeoxyglucose positron emission tomography/computed tomography used in diagnosing connective tissue diseases in fever of unknown origin/inflammatory of unk...
by Chen, Ziwei
Clinical rheumatology, 2021, Vol.41 (3), p.839-846
13.
Expert Consensus on clinical application of FDG PET/CT in infection and inflammation
by Li, Yaming
Annals of nuclear medicine, 2020, Vol.34 (5), p.369-376
14.
15.
Thoracic aorta calcification but not inflammation is associated with increased cardiovascular disease risk : results of the CAMONA study
by Blomberg, Bjorn A
European journal of nuclear medicine and molecular imaging, 2017, Vol.44 (2), p.249-258
16.
Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [18F] fluorodeoxyglucose and [18F]-fluoride PET/CT with whole-body MRI with diffusion-wei...
by Azad, Gurdip K
European journal of nuclear medicine and molecular imaging, 2018, Vol.46 (4), p.821-830
17.
Comparison of standard and delayed imaging to improve the detection rate of [68Ga]PSMA I&T PET/CT in patients with biochemical recurrence or prostate-specific antigen persistence a...
by Schmuck, Sebastian
European journal of nuclear medicine and molecular imaging, 2017, Vol.44 (6), p.960-968
18.
Clinical utility of F-18 FDG PET-CT in the initial evaluation of lung cancer
by Madsen, Poul Henning
European journal of nuclear medicine and molecular imaging, 2016, Vol.43 (11), p.2084-2097
19.
Prospective comparison of (4S)-4-(3- 18 F-fluoropropyl)-L-glutamate versus 18 F-fluorodeoxyglucose PET/CT for detecting metastases from pancreatic ductal adenocarcinoma: a proof-of...
by Cheng, Mei-Fang
European journal of nuclear medicine and molecular imaging, 2019, Vol.46 (4), p.810
20.
Developing and validating a novel metabolic tumor volume risk stratification system for supplementing non-small cell lung cancer staging
by Pu, Yonglin
European journal of nuclear medicine and molecular imaging, 2018, Vol.45 (12), p.2079-2092
